Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qingxuan Zhike Granules is a traditional Chinese medicine formulation indicated for the treatment of pediatric cough due to external wind-heat invasion. Its main functions are to disperse wind, clear heat, ventilate the lungs, and relieve cough. It is primarily used for children presenting with symptoms such as cough, expectoration (phlegm), fever or nasal congestion, runny nose, mild aversion to cold, and sore or red throat. The formula is derived from the classical prescription "Sangju Yin" and is recommended in multiple clinical guidelines for acute upper respiratory tract infections in children. It has been shown in clinical trials to be effective and safe for treating acute bronchitis with wind-heat syndrome[1][2][3][4][5]. The product is well-tolerated by children due to its palatable taste.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qingxuan Zhike Granules.